InvestSMART

Vanguard FTSE Europe Shares ETF (ASX: VEQ) - Share Price and Research

Current share price for VEQ : $70.990 0.19 (0.27%)+

Vanguard FTSE Europe Shares ETF (VEQ) is an Exchange Traded Fund - commonly known as an ETF. For more details about how ETFs work, feel free to check out our What is an ETF? overview. Vanguard FTSE Europe Shares ETF (VEQ) provides low-cost exposure to companies listed in major European markets. The ETF is exposed to the fluctuating values of foreign currencies, as there will not be any hedging of foreign currencies to the Australian dollar.

General Information

Vanguard FTSE Europe Shares ETF
Vanguard Investments Australia Ltd
Equity Europe
MSCI Europe NR USD
starstarstarstar
starstarstar (as at 31 Oct 2024)
Investment Fund
9 Dec 2015
$263.09 million (as at 31 Oct 2024)
$71.0519 (as at 25 Nov 2024)
$71.0519 (as at 25 Nov 2024)

VEQ ETF performance (31 Oct 2024)

NOTE : returns for periods greater than 1 year are annualised
  1 Month % 3 Month % 6 Month % 1 Year % p.a. 2 Year % p.a. 3 Year % p.a. 5 Year % p.a. 10 Year % p.a.
Total return 0.06 -2.03 2.89 18.41 17.31 6.48 7.34 -
Growth return -0.1 -2.18 1.45 15.41 14.27 3.62 4.65 -
Income return (Yield) 0.16 0.15 1.44 3 3.04 2.86 2.69 -

Market index (MSCI Europe NR USD)

Total return -5.89 -1.8 2.8 22.43 19.04 3 6.91 5.23

Asset Allocation (31 Oct 2024)

Australian Equities 0%
International Equities 98.45%
Cash 0.62%
Property 0.93%
Fixed Interest 0%
Alternatives 0%
Asset Allocation

Objectives and Strategy

Seeks to track the return of the FTSE Developed Europe All Cap Index (with net dividends reinvested) in Australian dollars, before taking into account fees, expenses and tax.
To track the performance of the benchmark Index, the Fund will invest substantially all of its assets in the US listed Vanguard FTSE Europe ETF listed on the New York Stock Exchange Arca (NYSE Code: VGK).

Offer information

MER 0.35% (as at 14 Nov 2024)
Indirect Cost Ratio (ICR) 0.35% (as at 30 Jun 2024)
Performance fee (not included in ICR) 0
Minimum initial investment

Top 10 holdings (as at 30 Sep 2024)

Holding Type % of Portfolio
Novo Nordisk AS Class B Equity 2.87%
Login now to view the complete list of holdings.

Fund data sourced from Morningstar. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only. Whilst every care has been taken in producing these numbers, neither Morningstar nor InvestSMART can make any guarantees around the complete accuracy of these figures. Should you decide to change investments, please read all relevant disclosure documents including the Product Disclosure Statements and if required, you may consider speaking to a financial professional for further guidance. A tax event may be realised as a result of switching investments. Past performance is not a reliable indicator of future performance.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.